CRP and rectal cancer: Thus, to find clinically relevant biomarkers of response to nCRT in rectal cancer patients, reinforce the results here presented, and better understand how CRP levels correlate with patient initial inflammatory status, we are now conducting a similar, but prospective, clinical study.